These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 6984294

  • 1. Circulating C3, C4, and C3 split products (C3c and C3d) during normal pregnancy.
    Teisner B, Hau J, Tucker M, Lahood J, Grudzinskas JG.
    Am J Reprod Immunol (1980); 1982 Dec; 2(6):309-11. PubMed ID: 6984294
    [Abstract] [Full Text] [Related]

  • 2. Development and clinical application of electroimmunoassays for the direct quantification of the complement C3 split products C3c and C3d.
    Brandslund I, Teisner B, Hyltoft Petersen P, Svehag SE.
    Scand J Clin Lab Invest Suppl; 1984 Dec; 168():57-73. PubMed ID: 6333715
    [Abstract] [Full Text] [Related]

  • 3. Influence of time, temperature and coagulation on the measurement of C3, C3 split products and C4.
    Sinosich MJ, Teisner B, Brandslund I, Fisher M, Grudzinskas JG.
    J Immunol Methods; 1982 Nov 26; 55(1):107-14. PubMed ID: 6818279
    [Abstract] [Full Text] [Related]

  • 4. Classical pathway activation during an adverse response to protamine sulphate.
    Best N, Teisner B, Grudzinskas JG, Fisher MM.
    Br J Anaesth; 1983 Nov 26; 55(11):1149-53. PubMed ID: 6605758
    [Abstract] [Full Text] [Related]

  • 5. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
    Petersen NE, Elmgreen J, Teisner B, Svehag SE.
    Acta Med Scand; 1988 Nov 26; 223(6):557-60. PubMed ID: 3389208
    [Abstract] [Full Text] [Related]

  • 6. The third complement factor (C3) and its in vivo cleavage products: interaction with lectins and precipitation with polyethylene glycol.
    Teisner B, Hau J, Svehag SE, Brandslund I, Bøg-Hansen TC.
    J Immunol Methods; 1984 Jan 20; 66(1):113-8. PubMed ID: 6607289
    [Abstract] [Full Text] [Related]

  • 7. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE, Harrison RA, Lachmann PJ.
    J Immunol; 1984 Apr 20; 132(4):1960-6. PubMed ID: 6607952
    [Abstract] [Full Text] [Related]

  • 8. Partial characterization of physiologically generated C3 components expressing C3d but not C3c epitopes.
    Siersted HC, Jensenius JC, Svehag SE, Brandslund I.
    J Clin Lab Immunol; 1983 Dec 20; 12(4):201-8. PubMed ID: 6198522
    [Abstract] [Full Text] [Related]

  • 9. The quantitation of C3d by routine methods after the direct absorption of human plasma with anti-C3c.
    Mlynek Y, Nilsson M.
    Acta Pathol Microbiol Immunol Scand C; 1985 Oct 20; 93(5):195-8. PubMed ID: 3936336
    [Abstract] [Full Text] [Related]

  • 10. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
    Berkowicz A, Kappelgaard E, Petersen J, Nielsen H, Ingemann-Hansen T, Halkjaer-Kristensen J, Sørensen H.
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec 20; 91(6):397-402. PubMed ID: 6608857
    [Abstract] [Full Text] [Related]

  • 11. Acute complement activation during an anaphylactoid reaction to blood transfusion and the disappearance rate of C3c and C3d from the circulation.
    Teisner B, Brandslund I, Grunnet N, Hansen LK, Thellesen J, Svehag SE.
    J Clin Lab Immunol; 1983 Oct 20; 12(2):63-7. PubMed ID: 6606048
    [Abstract] [Full Text] [Related]

  • 12. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S, Rairie JE, Carpenter AB, Kelly RH, Jagarlapudi SP, Sereika SM, Medsger TA, Ramsey-Goldman R.
    Arthritis Rheum; 1996 Jul 20; 39(7):1178-88. PubMed ID: 8670328
    [Abstract] [Full Text] [Related]

  • 13. Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus.
    Röther E, Lang B, Coldewey R, Hartung K, Peter HH.
    Clin Rheumatol; 1993 Mar 20; 12(1):31-5. PubMed ID: 8467609
    [Abstract] [Full Text] [Related]

  • 14. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
    Aguado MT, Lambris JD, Tsokos GC, Burger R, Bitter-Suermann D, Tamerius JD, Dixon FJ, Theofilopoulos AN.
    J Clin Invest; 1985 Oct 20; 76(4):1418-26. PubMed ID: 2932466
    [Abstract] [Full Text] [Related]

  • 15. Interaction of fibronectin with complement component C3.
    Hautanen A, Keski-Oja J.
    Scand J Immunol; 1983 Mar 20; 17(3):225-30. PubMed ID: 6402811
    [Abstract] [Full Text] [Related]

  • 16. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA, Senaldi G, Jawad AS, Berry H, Vergani D.
    Ann Rheum Dis; 1989 Apr 20; 48(4):302-6. PubMed ID: 2785367
    [Abstract] [Full Text] [Related]

  • 17. Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood.
    Miyano A, Nakayama M, Fujita T, Kitajima H, Imai S, Shimizu A.
    Diagn Clin Immunol; 1987 Apr 20; 5(2):86-90. PubMed ID: 3497734
    [Abstract] [Full Text] [Related]

  • 18. Detection of complement activation by counterimmunoelectrophoresis (CIE).
    Arroyave CM, Tan EM.
    J Immunol Methods; 1976 Apr 20; 13(2):101-12. PubMed ID: 824368
    [Abstract] [Full Text] [Related]

  • 19. A simple method for quantitative measurement of C3d in human plasma.
    Bhakdi S, Roth M, Nürnberger W.
    J Immunol Methods; 1984 Nov 16; 74(1):79-86. PubMed ID: 6438236
    [Abstract] [Full Text] [Related]

  • 20. Hypercatabolism of complement in Crohn's disease--assessment of circulating C3c.
    Elmgreen J, Berkowicz A, Sørensen H.
    Acta Med Scand; 1983 Nov 16; 214(5):403-7. PubMed ID: 6660048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.